000 | 01115 a2200313 4500 | ||
---|---|---|---|
005 | 20250517204633.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.24298 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJilkova, Zuzana Macek | |
245 | 0 | 0 |
_aCombination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma. _h[electronic resource] |
260 |
_bOncotarget _cFeb 2018 |
||
300 |
_a11145-11158 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aKuyucu, Ayca Zeybek | |
700 | 1 | _aKurma, Keerthi | |
700 | 1 | _aAhmad Pour, Séyédéh Tayébéh | |
700 | 1 | _aRoth, Gaël S | |
700 | 1 | _aAbbadessa, Giovanni | |
700 | 1 | _aYu, Yi | |
700 | 1 | _aSchwartz, Brian | |
700 | 1 | _aSturm, Nathalie | |
700 | 1 | _aMarche, Patrice N | |
700 | 1 | _aHainaut, Pierre | |
700 | 1 | _aDecaens, Thomas | |
773 | 0 |
_tOncotarget _gvol. 9 _gno. 13 _gp. 11145-11158 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.24298 _zAvailable from publisher's website |
999 |
_c28181137 _d28181137 |